Technology
Bio-based platform chemicals from bioethanol. One catalyst. One continuous step. Standard hardware. Designed for industrial scale.
Overview
Biosimo converts bioethanol into platform chemicals using a proprietary heterogeneous catalyst. Single-step continuous conversion in a standard fixed-bed reactor. The flagship product is bio-acetic acid — with acetaldehyde, ethyl acetate, and bio-VAM expanding the platform.
The catalyst has operated for 8,000+ hours with no significant activity loss. Four ethanol feedstocks from two continents validated — no feedstock-specific redesign required. The process runs on commercially proven unit operations: no first-of-a-kind hardware.
Up to 90% CO₂ reduction versus the fossil route. Designed to converge toward fossil parity as production scales — without structural bio-premium.
Process
Phase 1
Bioethanol and air enter a standard fixed-bed reactor.
Phase 2
Proprietary catalyst converts in a single continuous step.
Phase 3
Extraction and distillation — standard separation. Quality controlled to customer spec.
Phase 4
Industry-grade bio-acetic acid. Drop-in. Spec-stable from gram to multi-kilogram batches.
Sustainable chemicals built for
a better future
an industrial reality
Four ethanol sources from two continents validated. No feedstock-specific redesign. Geographic resilience built in.
Proprietary catalytic process. Lower energy input. Designed to compete at fossil economics — not dependent on green premiums or subsidies.
8,000+ hours stable catalyst operation. No first-of-a-kind hardware. Standard fixed-bed reactor, extraction, distillation. Built to run on existing infrastructure.
Bio-acetic acid available now. Bio-acetaldehyde, ethyl acetate, bio-VAM, and other acetyls on demand. Every product driven by customer demand.
ETH Zurich spin-off. Founded 2022. Zurich and Houston. Built with customers from day one. Qualified from two of the top three acetyls producers globally.